Disitamab Vedotin Plus Intravesical Mitomycin C in HER2-Expressing Intermediate- to High-Risk Non-Muscle-Invasive Bladder Cancer
Abroad (travel likely)RecruitingPHASE2
Conditions
Non-Muscle-Invasive Bladder Cancer (NMIBC)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Shanxi Provincial Cancer Hospital, Taiyuan, Shanxi, China